{"id":"NCT00332241","sponsor":"Otsuka Pharmaceutical Development & Commercialization, Inc.","briefTitle":"Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD)","officialTitle":"A Multicenter Double-Blind, Randomized, Placebo-Controlled, Flexible-Dosed, Parallel-Group Study of Aripiprazole Flexibly Dosed in the Treatment of Children and Adolescents With Autistic Disorder (AD)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-06","primaryCompletion":"2008-04","completion":"2008-04","firstPosted":"2006-06-01","resultsPosted":"2009-07-23","lastUpdate":"2013-12-02"},"enrollment":98,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Autistic Disorder"],"interventions":[{"type":"DRUG","name":"Aripiprazole","otherNames":["Abilify"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"A1","type":"EXPERIMENTAL"},{"label":"A2","type":"PLACEBO_COMPARATOR"}],"summary":"This study will compare the effectiveness (how well the drug works) of aripiprazole, flexibly dosed with a placebo, in reducing serious behavioral problems in children and adolescents with a diagnosis of autistic disorder (AD).","primaryOutcome":{"measure":"Mean Change (Week 8 - Baseline) in the Autistic Behavior Checklist (ABC) Irritability Subscale Score","timeFrame":"Week 8","effectByArm":[{"arm":"Placebo","deltaMin":-5,"sd":1.43},{"arm":"Aripiprazole","deltaMin":-12.9,"sd":1.44}],"pValues":[]},"eligibility":{"minAge":"6 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":7},"locations":{"siteCount":9,"countries":["United States"]},"refs":{"pmids":["19948625","24138011","21731831","20973712"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":47},"commonTop":["INCREASED APPETITE","FATIGUE","HEADACHE","SOMNOLENCE","VOMITING"]}}